The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors

Epigenomics. 2018 Dec;10(12):1569-1583. doi: 10.2217/epi-2017-0154. Epub 2018 Nov 14.

Abstract

Aim: To investigate the quantitative relationship between the positive detection rate (PDR) in colorectal tumor detection and the mSEPT9 level.

Materials & methods: The level of blood mSEPT9 in various colorectal diseases was quantified by the Epi proColon 2.0 assay. ΔΔCt values were calculated representing the mSEPT9 level. A total of 1347 subjects were recruited in this quantitative study.

Results: PDR or sensitivity was positively correlated with the progression of colorectal tumors and the mSEPT9 level in an exponential relationship. The mSEPT9 level of CRC exhibited a distinct pattern of distribution. Strong correlation was found between mSEPT9 level and PDR or sensitivity in various tumor differentiation, pathological types or metastasis.

Conclusion: The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.

Keywords: adenoma; colorectal cancer; ctDNA; methylation; polyps; sensitivity; septin 9; specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / blood*
  • Adenoma / diagnosis
  • Adenoma / genetics
  • Aged
  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / genetics
  • Colonic Polyps / blood*
  • Colonic Polyps / diagnosis
  • Colonic Polyps / genetics
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / genetics
  • DNA Methylation*
  • Early Detection of Cancer
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Precancerous Conditions / blood
  • Precancerous Conditions / diagnosis
  • Precancerous Conditions / genetics
  • Sensitivity and Specificity
  • Septins / blood*
  • Septins / genetics

Substances

  • Biomarkers, Tumor
  • SEPTIN9 protein, human
  • Septins